Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 74

Results For "population"

955 News Found

Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate
Drug Approval | March 24, 2022

Pfizer granted USFDA Breakthrough Therapy Designation for RSV vaccine candidate

The FDA decision is primarily informed by the positive results of a proof-of-concept, Phase 2a study evaluating the safety, immunogenicity, and efficacy of a single dose of 120µg RSVpreF in a human viral challenge model in healthy adults 18 to 50 years of age


Covovax for teens get DCGI nod
Drug Approval | March 23, 2022

Covovax for teens get DCGI nod

It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D


IHL launches first zero assistance integrated health centre
Public Health | March 23, 2022

IHL launches first zero assistance integrated health centre

The first-of-its-kind unique centre will increase access to preventive & primary care


Milltrust Ventures to invest in Oncoshot
Startup | March 22, 2022

Milltrust Ventures to invest in Oncoshot

Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes


Hester Biosciences foray into pet care industry
News | March 22, 2022

Hester Biosciences foray into pet care industry

Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


physIQ and CellCarta collaborate to personalise vaccine development
Biotech | March 21, 2022

physIQ and CellCarta collaborate to personalise vaccine development

Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness